分析性能规范在国际指南和标准中关于检验医学计量溯源性的作用
本文阐述了计量溯源性的目标是使临床样本结果不受体外诊断医疗器械影响而等效,ISO 17511规定了校准品、正确度控制品和人样本赋值计量溯源性的建立要求。溯源链每一步的不确定度累加,临床样本结果的合成不确定度须满足最大允许不确定度的分析性能规范,该规范可分解至各步骤并导出最大可接受非互换性偏倚标准;当前用室内质控数据估计重复性不确定度的时间间隔常不足以捕获所有变异来源,导致低估。
要点
- 计量溯源性的目标是使临床样本结果不受所用体外诊断医疗器械影响而等效。
- 临床样本结果的合成不确定度须满足最大允许不确定度的分析性能规范。
- 当前室内质控数据估计重复性不确定度常因时间间隔不足而低估。
核心结论
- 临床样本结果的合成不确定度必须满足最大允许不确定度的分析性能规范,该规范可分解至计量溯源校准层级各步骤以导出各步骤的最大允许不确定度。
研究设计与样本
- 本文为国际指南和标准类文件,由Clin Chem Lab Med发布,阐述分析性能规范在计量溯源性中的作用,未报告系统检索方法或样本量。
主要发现
- 计量溯源链每一步的不确定度累加,使合成不确定度逐步增大。
- 最大可接受非互换性偏倚的准则可由临床样本结果的最大允许不确定度导出。
- 多数现行基于室内质控数据估计重复性不确定度的建议未使用足够代表性的时间间隔以捕获所有相关变异来源,低估常见。
关键数值与推荐
- ISO 17511规定了用于体外诊断医疗器械的校准品、正确度控制品和人样本赋值计量溯源性的建立要求。
- 临床样本结果的合成不确定度须满足最大允许不确定度的分析性能规范。
- 最大可接受非互换性偏倚准则可由临床样本结果的最大允许不确定度导出。
临床怎么用
- 临床实验室应关注重复性不确定度估计的时间间隔是否足以捕获所有相关变异来源,避免低估而影响对体外诊断医疗器械及其校准层级满足临床需求的评估。
局限性
- 原文未报告具体研究设计、样本量或系统检索方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The goal of metrological traceability is to have equivalent results for a measurand in clinical samples (CSs) irrespective of the in-vitro diagnostic medical device (IVD-MD) used for measurements. The International Standards Organization standard 17511 defines requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples used with IVD-MDs. Each step in metrological traceability has an uncertainty associated with the value assigned to a material. The uncertainty at each step adds to the uncertainty from preceding steps such that the combined uncertainty gets larger at each step. The combined uncertainty for a CS result must fulfil an analytical performance specification (APS) for the maximum allowable uncertainty (umax CS). The umax CS can be partitioned among the steps in a metrological traceability calibration hierarachy to derive the APS for maximum allowable uncertainty at each step. Similarly, the criterion for maximum acceptable noncommutability bias can be derived from the umax CS. One of the challenges in determining if umax CS is fulfilled is determining the repeatability uncertainty (u Rw) from operating an IVD-MD within a clinical laboratory. Most of the current recommendations for estimating u Rw from internal quality control data do not use a sufficiently representative time interval to capture all relevant sources of variability in measurement results. Consequently, underestimation of u Rw is common and may compromise assessment of how well current IVD-MDs and their supporting calibration hierarchies meet the needs of clinical care providers.
引用
- Greg Miller W. The role of analytical performance specifications in international guidelines and standards dealing with metrological traceability in laboratory medicine. Clin Chem Lab Med. 2024. PMID: 38579121. doi:10.1515/cclm-2023-1201
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。